Company, which trades as Temmler Ireland here, said move would enable it to develop ‘innovative drug delivery systems’ ...

Pharmaceutical contract development and manufacturing firm Aenova has announced a significant expansion of its facility in ...

Aenova, a leading pharmaceutical Contract Development & Manufacturing Organisation (CDMO), has announced a significant expansion of their Killorglin facility (Temmler Ireland Ltd.) enabling the ...

A pharmaceutical company has announced a significant expansion to its facility in Killorglin which will create 10 new jobs.

“With our new hot melt extrusion technology, Aenova is expanding its range of innovative platforms to provide modern, ...

Achieving good oral bioavailability for targeted protein degraders (TPDs) is vital in providing a patient-friendly way to ...

Amorphous solid dispersions (ASDs) make a significant contribution to enhancing the solubility of poorly soluble drugs. The incorporation of surfactants in ASDs serves not only to facilitate the ...

10 new jobs are to be created in Killorglin, from a significant expansion of a leading pharmaceutical company. Aenova is a ...

The incorporation of this class of drugs into fully amorphous solid dispersions represents a well-known and efficient technology to address low bioavailability resulting from poor water-solubility.

Explore how in-line Raman and NIR spectroscopy, combined with chemometrics, enables real-time reaction monitoring for better ...